Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07329114Not ApplicableRecruiting

Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)

Role: lead

NCT02581085Phase 2Active Not Recruiting

Tocotrienol Against the Progression of End Stage Liver Disease

Role: lead

NCT02024243Terminated

Role of Tissue Oxygenation and the miR-210 Gene In Wound Healing

Role: lead

All 3 trials loaded